**Core Concept:**
The question is about a patient with recurrent headaches and an MRI finding of an extra-axial, dural-based, and enhancing lesion. These imaging features are suggestive of a meningioma, a common benign tumor originating from the arachnoid cells that line the meninges.

**Why the Correct Answer is Right:**
In this case, the correct answer is **D.** Meningioma is the most likely diagnosis due to the patient's age, presentation of headaches, and MRI findings. Meningiomas are the most common primary brain tumors in adults, with a peak incidence between the fourth and sixth decades of life. These tumors are extra-axial, dural-based, and can cause various neurological symptoms depending on their location. The enhancing lesion on MRI is consistent with the tumor's vascular nature, as they are often richly vascularized and demonstrate enhancement after contrast administration.

**Why Each Wrong Option is Incorrect:**

A. **Option A (Ependymoma):** Ependymomas are rare tumors arising from the ependymal cells lining the ventricles or central canal of the spinal cord. They are typically seen in children and young adults and are intra-axial, contrasting with the extra-axial nature of the tumor in this case.

B. **Option B (Glioma):** Gliomas are tumors arising from glial cells in the central nervous system. They are predominantly intra-axial and often associated with neurological deficits, while the clinical presentation and MRI findings in this case are more consistent with a meningioma.

C. **Option C (Neurocytoma):** Neurocytomas are rare tumors arising from the neurons of the hypothalamus. They are typically observed in young adults and are characterized by the presence of a mass effect, which is not the case in this scenario.

**Clinical Pearl:** Meningiomas are benign tumors arising from the arachnoid cells of the meninges. They are commonly seen in women between the fourth and sixth decades of life and are responsible for a wide variety of neurological symptoms depending on their location. Surgical intervention is the primary treatment for meningiomas, and the prognosis is generally favorable, with a high rate of complete tumor removal and low recurrence rates.